DCGI

Govt Panel Okays Oxford Vaccine In India, DCGI To Take Final Call On Rollout

New Delhi: A day ahead of the scheduled dry run for vaccination in all the states, a government-appointed panel of…

January 1, 2021

Zydus Cadila Gets DGCI Approval For Phase Three Clinical Trials With Biological Therapy

New Delhi: Drug firm Zydus Cadila has received approval from the Drugs Controller General of India (DCGI) to start phase…

December 4, 2020

COVID-19 Vaccine: DCGI Gives Its Nod To Bharat Biotech’s Covaxin For Phase 3 Trial

New Delhi: The Bharat Biotech developed-vaccine in collaboration with the Indian Council of Medical Research (ICMR) — Covaxin — has…

October 23, 2020

ICMR Develops Antibody Treatment For Coronavirus From Horses

New Delhi: The Indian Council of Medical Research (ICMR) has developed an ‘antisera’ for the treatment of coronavirus. It has…

October 7, 2020

Serum Institute To Start Final Phase Of COVID Vaccine Trial Next Week

Pune: The Serum Institute of India (SII) will start the third and final phase of human trial of Oxford-Astrazeneca’s coronavirus…

September 19, 2020

DCGI Orders Serum Institute To Suspend Recruitment For Oxford COVID Vaccine Candidate Trials

New Delhi: With pharma giant AstraZeneca pausing the Oxford COVID-19 vaccine candidate's trials in other countries, the Serum Institute of…

September 12, 2020

DCGI Gives Green Signal To Oxford COVID Vaccine’s Human Trials In India

New Delhi: The Drugs Controller General of India (DCGI) has given green signal to Pune-based Serum Institute of India (SII)…

August 3, 2020

Another Pharma Company Gets DCGI Nod To Launch COVID-19 Drug; Know The Price Per Dose

New Delhi: Drug firm Hetero has received approval from Drug Controller General of India (DCGI) to manufacture and market antiviral…

June 22, 2020

Fighting COVID-19: Four Indian Hospitals To Take Part In WHO’s Solidarity Trial

New Delhi: Four Covid-19 hospitals in India have received clearance to be part of the World Health Organisation’s (WHO) clinical…

May 8, 2020